Timber Hill’s Amedisys AMED Stock Holding History

Timber Hill’s Portfolio AMED Stock Details AMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q1	–	Sell	-15,243	Closed	-$235K	–	2683
2013 Q4	$223K	Buy	+15,243	New	+$245K	﹤0.01%	2774

Other funds holding AMED

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

KKRC

Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Timber Hill's AMED Position: Q1 2014 in Review

Timber Hill sold out of Amedisys (AMED) in Q1 2014, closing a stake of 15,243 shares — an estimated $235K sold.

Timber Hill first reported a position in AMED in Q4 2013 and held it in 1 quarter. The position peaked at $223K in Q4 2013. 120 funds tracked by Wall St. Rank hold AMED as of Q1 2014.

Timber Hill reported no remaining Amedisys position as of Q1 2014 after selling out during the quarter.
Timber Hill sold 15,243 Amedisys shares in Q1 2014, an estimated $235K.
Timber Hill first reported a position in Amedisys in Q4 2013 and held it in 1 quarter.
Timber Hill's Amedisys position peaked at $223K in Q4 2013.
120 funds tracked by Wall St. Rank held Amedisys as of Q1 2014.

Based on Timber Hill's 13F filing for Q1 2014, filed 13 May 2014.